Your browser doesn't support javascript.
loading
Phase IB study of ziv-aflibercept plus pembrolizumab in patients with advanced solid tumors.
Rahma, Osama E; Tyan, Kevin; Giobbie-Hurder, Anita; Brohl, Andrew S; Bedard, Philippe L; Renouf, Daniel J; Sharon, Elad; Streicher, Howard; Hathaway, Emma; Cunningham, Rachel; Manos, Michael; Severgnini, Mariano; Rodig, Scott; Stephen Hodi, F.
Affiliation
  • Rahma OE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA osamae_rahma@dfci.harvard.edu.
  • Tyan K; Harvard Medical School, Boston, Massachusetts, USA.
  • Giobbie-Hurder A; Harvard Medical School, Boston, Massachusetts, USA.
  • Brohl AS; Division of Biostatistics, Department of Data Sciences, Dana Farber Cancer Institute, Boston, Massachusetts, USA.
  • Bedard PL; Sarcoma Department and Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida, USA.
  • Renouf DJ; Division of Medical Oncology and Hematology, University Health Network, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Sharon E; Cancer and Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Streicher H; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland, USA.
  • Hathaway E; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland, USA.
  • Cunningham R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Manos M; Center for Immuno-Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA.
  • Severgnini M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Rodig S; Center for Immuno-Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA.
  • Stephen Hodi F; Center for Immuno-Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA.
J Immunother Cancer ; 10(3)2022 03.
Article in En | MEDLINE | ID: mdl-35264434
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Kidney Neoplasms / Melanoma Type of study: Clinical_trials Limits: Female / Humans / Male Language: En Journal: J Immunother Cancer Year: 2022 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Kidney Neoplasms / Melanoma Type of study: Clinical_trials Limits: Female / Humans / Male Language: En Journal: J Immunother Cancer Year: 2022 Type: Article Affiliation country: United States